LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 24.09 | 27.76 | 37 | 1461 | 0.0253 | 0.0515 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 24.09 | 27.76 | 1217 | 1461 | 0.8326 | 0.9370 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 25.79 | 27.76 | 128 | 1605 | 0.0797 | 0.2984 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 25.79 | 27.76 | 1107 | 1605 | 0.6897 | 0.8770 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 25.79 | 27.76 | 43 | 1605 | 0.0268 | 0.0776 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 25.79 | 27.76 | 1227 | 1605 | 0.7644 | 0.9103 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 27.49 | 27.76 | 172 | 1723 | 0.0998 | 0.3583 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 27.49 | 27.76 | 1155 | 1723 | 0.6703 | 0.8701 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 27.49 | 27.76 | 51 | 1723 | 0.0296 | 0.1075 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 27.49 | 27.76 | 1254 | 1723 | 0.7277 | 0.8961 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 29.19 | 27.76 | 178 | 1863 | 0.0955 | 0.3583 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 29.19 | 27.76 | 1181 | 1863 | 0.6339 | 0.8553 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 29.19 | 27.76 | 70 | 1863 | 0.0376 | 0.1646 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 29.19 | 27.76 | 1321 | 1863 | 0.7090 | 0.8898 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 30.90 | 27.76 | 204 | 2032 | 0.1004 | 0.3799 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 30.90 | 27.76 | 1260 | 2032 | 0.6200 | 0.8514 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 30.90 | 27.76 | 77 | 2032 | 0.0379 | 0.1791 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 30.90 | 27.76 | 1368 | 2032 | 0.6731 | 0.8762 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 32.60 | 27.76 | 228 | 2235 | 0.1020 | 0.3946 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 32.60 | 27.76 | 1290 | 2235 | 0.5770 | 0.8336 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 32.60 | 27.76 | 82 | 2235 | 0.0367 | 0.1866 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 32.60 | 27.76 | 1406 | 2235 | 0.6288 | 0.8587 | MN20160318_Q01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 34.30 | 27.76 | 242 | 2449 | 0.0988 | 0.3980 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 34.30 | 27.76 | 1358 | 2449 | 0.5543 | 0.8255 | MN20160318_Q01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 34.30 | 27.76 | 103 | 2449 | 0.0420 | 0.2249 | MN20160318_Q01 | L15 |